In mid-2013, Mrs. Nurhayati was pregnant with her first child when she received the devastating diagnosis of breast cancer. Despite being only two months pregnant, she underwent a mastectomy due to the aggressive nature of the cancer, confirmed by histopathological examination as Non-Special Type (NST), Grade 3 NST Breast Cancer. Subsequently, she endured a series of chemotherapy sessions.
2013年中期，Nurhayati女士怀了她的第一个孩子，却在怀孕仅两个月时接到了乳腺癌的毁灭性诊断。尽管怀孕仅两个月，由于癌症的侵略性，她接受了乳房切除手术，经组织病理学检查确认为NST（非特异性类型）三级。随后，她经历了一系列的化疗。The challenges did not end there. In addition to undergoing chemotherapy after breast removal surgery, she also had to undergo a hysterectomy, necessitating the termination of her pregnancy. Faced with an agonizing dilemma, Mrs. Nurhayati and her husband grappled with the decision to fight against both the high-grade cancer threatening her life and the loss of their unborn child, their firstborn.
挑战并没有就此结束。除了在乳腺切除手术后接受化疗外，她还必须接受子宫切除手术，导致怀孕终止。面对这个令人痛苦的困境，Nurhayati女士和她的丈夫为与威胁她生命的高级癌症作斗争和失去他们未出生的孩子（他们的长子）两难的决定而苦苦挣扎。Amidst this difficult decision-making process, Mrs. Nurhayati learned about ECCT, facing the decision of her life or her first unborn child, she could not make up her mind. She started ECCT as an alternative that does not harm her pregnancy, trying to gain some control over her aggressive cancer while trying to digest her option and trying her very best to preserving her pregnancy.
在这个艰难的决策过程中，Nurhayati女士得知了ECCT，面对她的生命或她的第一个未出生的孩子的抉择，她无法下定决心。她开始尝试ECCT作为一种不损害怀孕的替代方法，试图在尽力保持怀孕的同时控制她侵略性的癌症。Initially, the progress with ECCT therapy was slow due to the pregnancy hormonal changes being a crucial factor that can hinder most breast cancer therapy, including ECCT therapy. The followings ongoing scans showing increasing activity and delayed wound healing from the surgical incisions. However, Mrs. Nurhayati remained steadfast in her therapy regimen.
最初，由于怀孕激素变化是影响大多数乳腺癌疗法的关键因素，包括ECCT疗法，因此ECCT疗法进展缓慢。随后进行的扫描显示手术切口的活动增加和愈合延迟。然而，Nurhayati女士始终坚定不移地遵循她的治疗方案。Eventually, she safely gave birth to her first child, and her surgical wounds began to heal. Areas around the incisions that had previously exhibited re-emerging growth also darkened, dried up, and fell off after delivery. Within a year of commencing ECCT therapy, Mrs. Nurhayati's cancer was effectively eradicated. Subsequent developments showed no recurrence of cancer for Mrs. Nurhayati. She remained cancer-free without chemotherapy or hysterectomy. Five years later, she gave birth to her second child, followed by a third child two years after. Ten years since her initial breast cancer diagnosis, Mrs. Nurhayati remains in good health, as do her three children. She continues to use ECCT therapy preventively.
最终，她顺利地生下了她的第一个孩子，手术切口开始愈合。之前出现再次生长的部位也在分娩后变黑、干燥并脱落。在开始ECCT治疗后的一年内，Nurhayati女士的癌症被有效根除。随后的发展显示Nurhayati女士没有癌症复发。她没有接受化疗或子宫切除手术而保持了癌症的免疫。五年后，她又生下了第二个孩子，两年后又生下了第三个孩子。自首次乳腺癌诊断以来的十年里，Nurhayati女士和她的三个孩子都保持良好的健康状态。她继续预防性地使用ECCT疗法。
Comments